General Information

Myx Therapeutics Inc.

	Address	160 - 4 Car. Westmount Westmount, H3Z 2S6 Canada
	Address type	Registered Office Address
	Address province	Quebec

	Corporation ID	10274119
	Business number	710261298
	Status	Inactive - Amalgamated
	ACT	Canada Business Corporations Act
	Anniversary date	06/09/2017
	Last annual filing	2021
	Data verified	10/31/2026

Description

Myx Therapeutics Inc. is an inactive - amalgamated establishment which was registered under Canada Business Corporations Act with a corporation no 10274119 (business no 710261298). The amendment was done on 2018-08-08. The company is headquartered in Westmount at 160 - 4 Car. Westmount, H3Z 2S6 in Quebec administrative division.
Additional enterprises in the vicinity are: Dr. Beatrice Wang, Inc., Ingrid On Greene Inc., 4382196 Canada Inc., Ioanniscorp. Inc., La Clinique De L'avenue Greene Inc..

Approximate location (postal code area): GeoNames (CC BY 4.0).

Company names

Name	Effective date	Type	Current
EOSINATE THERAPEUTICS INC.	06/09/2017	Corporate Name
EOSINATE THÉRAPEUTIQUE INC.	06/09/2017	Corporate Name in the other official language (if applicable)
MyX Thérapeutique inc.	11/02/2026	Corporate Name in the other official language (if applicable)
MyX Therapeutics Inc.	11/02/2026	Corporate Name	true

Directors

Maxime RANGER
,

Gregory Lee WHITE
,

last updated: 2026-10-30

Government Grants and Contributions

2 federal grants and contributions in 2020 with a total value of $24,590.

Start date	Department and program	Value
06/25/2020	National Research Council Canada Industrial Research Assistance Program – Innovation Assistance Program (contribution) Innovation Assistance Program – Round 2 The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.	$14,426
04/01/2020	National Research Council Canada Innovation Assistance Program (contribution) The funding provided from the IAP program is to assist innovative, early stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.	$10,164

Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.

Company activities

Date	Type	Section
08/08/2018	Amendment	6
07/19/2018	Amendment	6
06/09/2017	Incorporation